Contribution of air pollution to COPD and small airway dysfunction

Respirology

Volumn 21, Issue 2, 2016, Pages 237-244

  Berend, Norbert ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

air pollution; chronic obstructive pulmonary disease; peripheral airway; spirometry; study design

Indexed keywords

NITROGEN DIOXIDE; OZONE; SULFUR DIOXIDE; AIR POLLUTANT; PARTICULATE MATTER;

AIR POLLUTANT; AIR POLLUTION; AIR QUALITY; AIRBORNE PARTICLE; AIRWAY REMODELING; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INDOOR AIR POLLUTION; INFLAMMATION; LONG TERM EXPOSURE; LUNG EMPHYSEMA; OXIDATIVE STRESS; PARTICULATE MATTER; PRIORITY JOURNAL; RISK FACTOR; SMALL AIRWAY DISEASE; SMOKING; TRAFFIC; ADVERSE EFFECTS; ANALYSIS; BRONCHIOLE; DRUG EFFECTS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AIR POLLUTANTS; AIR POLLUTION; AIRWAY REMODELING; BRONCHIOLES; HUMANS; OXIDATIVE STRESS; PARTICULATE MATTER; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84955267499     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12644     Document Type: Article

References (91)

1. Air Quality guidelines for particulate matter, ozone, nitrogen dioxide and sulphur dioxide. World Health Organization. 2005.
2. Ambient (outdoor) air quality and health. World Health Organization. 2014.
3. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260.
4. Oberdorster G, Ferin J, Lehnert BE,. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect. 1994; 102 (Suppl. 5): 173-179.
5. MacNee W, Donaldson K,. Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. Eur. Respir. J. Suppl. 2003; 40: 47s-51s.
6. Stone V, Tuinman M, Vamvakopoulos JE, Shaw J, Brown D, Petterson S, Faux SP, Borm P, MacNee W, Michaelangeli F, et al. Increased calcium influx in a monocytic cell line on exposure to ultrafine carbon black. Eur. Respir. J. 2000; 15: 297-303.
7. Alessandrini F, Weichenmeier I, van Miert E, Takenaka S, Karg E, Blume C, Mempel M, Schulz H, Bernard A, Behrendt H,. Effects of ultrafine particles-induced oxidative stress on Clara cells in allergic lung inflammation. Part. Fibre Toxicol. 2010; 7: 11.
8. Kumar RK, Shadie AM, Bucknall MP, Rutlidge H, Garthwaite L, Herbert C, Halliburton B, Parsons KS, Wark PA,. Differential injurious effects of ambient and traffic-derived particulate matter on airway epithelial cells. Respirology 2015; 20: 73-79.
9. Ristovski ZD, Miljevic B, Surawski NC, Morawska L, Fong KM, Goh F, Yang IA,. Respiratory health effects of diesel particulate matter. Respirology 2012; 17: 201-212.
10. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ,. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am. J. Respir. Crit. Care Med. 2000; 162: 1175-1177.
11. Laumbach RJ, Kipen HM,. Acute effects of motor vehicle traffic-related air pollution exposures on measures of oxidative stress in human airways. Ann. N. Y. Acad. Sci. 2010; 1203: 107-112.
12. Rich DQ, Kipen HM, Huang W, Wang G, Wang Y, Zhu P, Ohman-Strickland P, Hu M, Philipp C, Diehl SR, et al. Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults. JAMA 2012; 307: 2068-2078.
13. Huang W, Wang G, Lu SE, Kipen H, Wang Y, Hu M, Lin W, Rich D, Ohman-Strickland P, Diehl SR, et al. Inflammatory and oxidative stress responses of healthy young adults to changes in air quality during the Beijing Olympics. Am. J. Respir. Crit. Care Med. 2012; 186: 1150-1159.
14. Kipen H, Rich D, Huang W, Zhu T, Wang G, Hu M, Lu SE, Ohman-Strickland P, Zhu P, Wang Y, et al. Measurement of inflammation and oxidative stress following drastic changes in air pollution during the Beijing Olympics: a panel study approach. Ann. N. Y. Acad. Sci. 2010; 1203: 160-167.
15. Calderon-Garciduenas L, Villarreal-Calderon R, Valencia-Salazar G, Henriquez-Roldan C, Gutierrez-Castrellon P, Torres-Jardon R, Osnaya-Brizuela N, Romero L, Torres-Jardon R, Solt A, et al. Systemic inflammation, endothelial dysfunction, and activation in clinically healthy children exposed to air pollutants. Inhal. Toxicol. 2008; 20: 499-506.
16. van Eeden SF, Tan WC, Suwa T, Mukae H, Terashima T, Fujii T, Qui D, Vincent R, Hogg JC,. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM10). Am. J. Respir. Crit. Care Med. 2001; 164: 826-830.
17. Tan WC, Qiu D, Liam BL, Ng TP, Lee SH, van Eeden SF, D'Yachkova Y, Hogg JC,. The human bone marrow response to acute air pollution caused by forest fires. Am. J. Respir. Crit. Care Med. 2000; 161: 1213-1217.
18. Sakai M, Sato Y, Sato S, Ihara S, Onizuka M, Sakakibara Y, Takahashi H,. Effect of relocating to areas of reduced atmospheric particulate matter levels on the human circulating leukocyte count. J. Appl. Physiol. 2004; 97: 1774-1780.
19. Loxham M,. Harmful effects of particulate air pollution: identifying the culprits. Respirology 2015; 20: 7-8.
20. Gan WQ, Man SF, Senthilselvan A, Sin DD,. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
21. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG,. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 186: 982-988.
22. Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE 2012; 7: e37483.
23. Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, Hurst JR, Maccallum PK, Wedzicha JA,. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005; 128: 1995-2004.
24. Moller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Haussinger K, Kreyling WG,. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am. J. Respir. Crit. Care Med. 2008; 177: 426-432.
25. Kim CS, Jaques PA,. Respiratory dose of inhaled ultrafine particles in healthy adults. Philos. Trans. R. Soc. Lond. 2000; 358: 2693-2705.
26. Churg A, Brauer M, del Carmen Avila-Casado M, Fortoul TI, Wright JL,. Chronic exposure to high levels of particulate air pollution and small airway remodeling. Environ. Health Perspect. 2003; 111: 714-718.
27. Andersen ZJ, Hvidberg M, Jensen SS, Ketzel M, Loft S, Sorensen M, Tjonneland A, Overvad K, Raaschou-Nielsen O,. Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study. Am. J. Respir. Crit. Care Med. 2011; 183: 455-461.
28. Islam T, Gauderman WJ, Berhane K, McConnell R, Avol E, Peters JM, Gilliland FD,. Relationship between air pollution, lung function and asthma in adolescents. Thorax 2007; 62: 957-963.
29. Liu L, Poon R, Chen L, Frescura AM, Montuschi P, Ciabattoni G, Wheeler A, Dales R,. Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. Environ. Health Perspect. 2009; 117: 668-674.
30. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005; 26: 948-968.
31. Lagorio S, Forastiere F, Pistelli R, Iavarone I, Michelozzi P, Fano V, Marconi A, Ziemacki G, Ostro BD,. Air pollution and lung function among susceptible adult subjects: a panel study. Environ. Health 2006; 5: 11.
32. Yoda Y, Otani N, Sakurai S, Shima M,. Acute effects of summer air pollution on pulmonary function and airway inflammation in healthy young women. J. Epidemiol. 2014; 24: 312-320.
33. Sunyer J, Schwartz J, Tobias A, Macfarlane D, Garcia J, Anto JM,. Patients with chronic obstructive pulmonary disease are at increased risk of death associated with urban particle air pollution: a case-crossover analysis. Am. J. Epidemiol. 2000; 151: 50-56.
34. Alexeeff SE, Litonjua AA, Suh H, Sparrow D, Vokonas PS, Schwartz J,. Ozone exposure and lung function: effect modified by obesity and airways hyperresponsiveness in the VA normative aging study. Chest 2007; 132: 1890-1897.
35. Adam M, Schikowski T, Carsin AE, Cai Y, Jacquemin B, Sanchez M, Vierkotter A, Marcon A, Keidel D, Sugiri D, et al. Adult lung function and long-term air pollution exposure. ESCAPE: a multicentre cohort study and meta-analysis. Eur. Respir. J. 2015; 45: 38-50.
36. Schindler C, Kunzli N, Bongard JP, Leuenberger P, Karrer W, Rapp R, Monn C, Ackermann-Liebrich U,. Short-term variation in air pollution and in average lung function among never-smokers. The Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA). Am. J. Respir. Crit. Care Med. 2001; 163: 356-361.
37. Dockery DW, Pope CA III., Acute respiratory effects of particulate air pollution. Annu. Rev. Public Health 1994; 15: 107-132.
38. Weichenthal S, Kulka R, Dubeau A, Martin C, Wang D, Dales R,. Traffic-related air pollution and acute changes in heart rate variability and respiratory function in urban cyclists. Environ. Health Perspect. 2011; 119: 1373-1378.
39. Schwartz J,. Lung function and chronic exposure to air pollution: a cross-sectional analysis of NHANES II. Environ. Res. 1989; 50: 309-321.
40. Peters JM, Avol E, Gauderman WJ, Linn WS, Navidi W, London SJ, Margolis H, Rappaport E, Vora H, Gong H Jr, et al. A study of twelve Southern California communities with differing levels and types of air pollution. II. Effects on pulmonary function. Am. J. Respir. Crit. Care Med. 1999; 159: 768-775.
41. Gauderman WJ, Avol E, Gilliland F, Vora H, Thomas D, Berhane K, McConnell R, Kuenzli N, Lurmann F, Rappaport E, et al. The effect of air pollution on lung development from 10 to 18 years of age. N. Engl. J. Med. 2004; 351: 1057-1067.
42. Ackermann-Liebrich U, Leuenberger P, Schwartz J, Schindler C, Monn C, Bolognini G, Bongard JP, Brandli O, Domenighetti G, Elsasser S, et al. Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. Am. J. Respir. Crit. Care Med. 1997; 155: 122-129.
43. Forbes LJ, Kapetanakis V, Rudnicka AR, Cook DG, Bush T, Stedman JR, Whincup PH, Strachan DP, Anderson HR,. Chronic exposure to outdoor air pollution and lung function in adults. Thorax 2009; 64: 657-663.
44. Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann HE, Kramer U,. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir. Res. 2005; 6: 152.
45. Gotschi T, Heinrich J, Sunyer J, Kunzli N,. Long-term effects of ambient air pollution on lung function: a review. Epidemiology 2008; 19: 690-701.
46. Abbey DE, Burchette RJ, Knutsen SF, McDonnell WF, Lebowitz MD, Enright PL,. Long-term particulate and other air pollutants and lung function in nonsmokers. Am. J. Respir. Crit. Care Med. 1998; 158: 289-298.
47. Frye C, Hoelscher B, Cyrys J, Wjst M, Wichmann HE, Heinrich J,. Association of lung function with declining ambient air pollution. Environ. Health Perspect. 2003; 111: 383-387.
48. Avol EL, Gauderman WJ, Tan SM, London SJ, Peters JM,. Respiratory effects of relocating to areas of differing air pollution levels. Am. J. Respir. Crit. Care Med. 2001; 164: 2067-2072.
49. Downs SH, Schindler C, Liu LJ, Keidel D, Bayer-Oglesby L, Brutsche MH, Gerbase MW, Keller R, Kunzli N, Leuenberger P, et al. Reduced exposure to PM10 and attenuated age-related decline in lung function. N. Engl. J. Med. 2007; 357: 2338-2347.
50. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
51. Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB,. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am. J. Respir. Crit. Care Med. 2009; 180: 3-10.
52. Sunyer J,. Urban air pollution and chronic obstructive pulmonary disease: a review. Eur. Respir. J. 2001; 17: 1024-1033.
53. Ko FW, Hui DS,. Air pollution and chronic obstructive pulmonary disease. Respirology 2012; 17: 395-401.
54. Schikowski T, Mills IC, Anderson HR, Cohen A, Hansell A, Kauffmann F, Kramer U, Marcon A, Perez L, Sunyer J, et al. Ambient air pollution: a cause of COPD? Eur. Respir. J. 2014; 43: 250-263.
55. Tashkin DP, Detels R, Simmons M, Liu H, Coulson AH, Sayre J, Rokaw S,. The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second. Am. J. Respir. Crit. Care Med. 1994; 149: 1209-1217.
56. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, et al. Changes in forced expiratory volume in 1 second over time in COPD. N. Engl. J. Med. 2011; 365: 1184-1192.
57. Detels R, Tashkin DP, Sayre JW, Rokaw SN, Massey FJ Jr, Coulson AH, Wegman DH,. The UCLA population studies of CORD: X. A cohort study of changes in respiratory function associated with chronic exposure to SOx, NOx, and hydrocarbons. Am. J. Public Health 1991; 81: 350-359.
58. Chen BH, Hong CJ, Pandey MR, Smith KR,. Indoor air pollution in developing countries. World Health Stat. Q. 1990; 43: 127-138.
59. Campbell H, Armstrong JR, Byass P,. Indoor air pollution in developing countries and acute respiratory infection in children. Lancet 1989; 1: 1012.
60. Kossove D,. Smoke-filled rooms and lower respiratory disease in infants. S. Afr. Med. J. 1982; 61: 622-624.
61. Woolcock AJ, Blackburn CR, Freeman MH, Zylstra W, Spring SR,. Studies of chronic (nontuberculous) lung disease in New Guinea populations. The nature of the disease. Am. Rev. Respir. Dis. 1970; 102: 575-590.
62. Regalado J, Perez-Padilla R, Sansores R, Paramo Ramirez JI, Brauer M, Pare P, Vedal S,. The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women. Am. J. Respir. Crit. Care Med. 2006; 174: 901-905.
63. Pandey MR,. Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal. Thorax 1984; 39: 337-339.
64. Malik SK,. Exposure to domestic cooking fuels and chronic bronchitis. Indian J. Chest Dis. Allied Sci. 1985; 27: 171-174.
65. Perez-Padilla R, Regalado J, Vedal S, Pare P, Chapela R, Sansores R, Selman M,. Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. Am. J. Respir. Crit. Care Med. 1996; 154: 701-706.
66. Menezes AM, Victora CG, Rigatto M,. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study. Thorax 1994; 49: 1217-1221.
67. Liu S, Zhou Y, Wang X, Wang D, Lu J, Zheng J, Zhong N, Ran P,. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 2007; 62: 889-897.
68. Ekici A, Ekici M, Kurtipek E, Akin A, Arslan M, Kara T, Apaydin Z, Demir S,. Obstructive airway diseases in women exposed to biomass smoke. Environ. Res. 2005; 99: 93-98.
69. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am. J. Respir. Crit. Care Med. 2007; 176: 753-760.
70. Orozco-Levi M, Garcia-Aymerich J, Villar J, Ramirez-Sarmiento A, Anto JM, Gea J,. Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur. Respir. J. 2006; 27: 542-546.
71. Dennis RJ, Maldonado D, Norman S, Baena E, Martinez G,. Woodsmoke exposure and risk for obstructive airways disease among women. Chest 1996; 109: 115-119.
72. Ramirez-Venegas A, Sansores RH, Quintana-Carrillo RH, Velazquez-Uncal M, Hernandez-Zenteno RJ, Sanchez-Romero C, Velazquez-Montero A, Flores-Trujillo F,. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. Am. J. Respir. Crit. Care Med. 2014; 190: 996-1002.
73. Albalak R, Frisancho AR, Keeler GJ,. Domestic biomass fuel combustion and chronic bronchitis in two rural Bolivian villages. Thorax 1999; 54: 1004-1008.
74. Ozbay B, Uzun K, Arslan H, Zehir I,. Functional and radiological impairment in women highly exposed to indoor biomass fuels. Respirology 2001; 6: 255-258.
75. Sandoval J, Salas J, Martinez-Guerra ML, Gomez A, Martinez C, Portales A, Palomar A, Villegas M, Barrios R,. Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. Chest 1993; 103: 12-20.
76. Camp PG, Ramirez-Venegas A, Sansores RH, Alva LF, McDougall JE, Sin DD, Pare PD, Muller NL, Silva CI, Rojas CE, et al. COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur. Respir. J. 2014; 43: 725-734.
77. Rivera RM, Cosio MG, Ghezzo H, Salazar M, Perez-Padilla R,. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int. J. Tuberc. Lung Dis. 2008; 12: 972-977.
78. Grobbelaar JP, Bateman ED,. Hut lung: a domestically acquired pneumoconiosis of mixed aetiology in rural women.[erratum appears in Thorax 1991 Jul;46(7):544]. Thorax 1991; 46: 334-340.
79. Ramirez-Venegas A, Sansores RH, Perez-Padilla R, Regalado J, Velazquez A, Sanchez C, Mayar ME,. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am. J. Respir. Crit. Care Med. 2006; 173: 393-397.
80. Mohamed Hoesein FA, van Rikxoort E, van Ginneken B, de Jong PA, Prokop M, Lammers JW, Zanen P,. Computed tomography-quantified emphysema distribution is associated with lung function decline. Eur. Respir. J. 2012; 40: 844-850.
81. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 185: 44-52.
82. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N. Engl. J. Med. 2011; 365: 1567-1575.
83. Anthonisen NR, Connett JE, Murray RP,. Smoking and lung function of Lung Health Study participants after 11 years. Am. J. Respir. Crit. Care Med. 2002; 166: 675-679.
84. Lange P, Celli B, Agusti A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N. Engl. J. Med. 2015; 373: 111-122.
85. Hnizdo E, Sircar K, Yan T, Harber P, Fleming J, Glindmeyer HW,. Limits of longitudinal decline for the interpretation of annual changes in FEV1 in individuals. Occup. Environ. Med. 2007; 64: 701-707.
86. Townsend MC,. Evaluating pulmonary function change over time in the occupational setting. J. Occup. Environ. Med. 2005; 47: 1307-1316.
87. Olofsson J, Bake B, Svardsudd K, Skoogh BE,. The single breath N2-test predicts the rate of decline in FEV1. The study of men born in 1913 and 1923. Eur. J. Respir. Dis. 1986; 69: 46-56.
88. Stanescu D, Sanna A, Veriter C, Robert A,. Identification of smokers susceptible to development of chronic airflow limitation. Chest 1998; 114: 416-425.
89. Buist AS, Vollmer WM, Johnson LR, McCamant LE,. Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation? Am. Rev. Respir. Dis. 1988; 137: 293-301.
90. Verbanck S, Schuermans D, Van Muylem A, Melot C, Noppen M, Vincken W, Paiva M,. Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD. Am. J. Respir. Crit. Care Med. 1998; 157: 1573-1577.
91. Verbanck S, Schuermans D, Meysman M, Paiva M, Vincken W,. Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am. J. Respir. Crit. Care Med. 2004; 170: 414-419.